How good are systemic symptoms and blood inflammatory markers at detecting individuals with tuberculosis?

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 1, 2008, Pages 44-49

  Breen, Ronan A M ^a,c   Leonard, O ^a   Perrin, F M R ^a   Smith, C J ^b   Bhagani, S ^a   Cropley, I ^a   Lipman, M C I ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

C reactive protein; Diagnosis; Symptoms; Tuberculosis

Indexed keywords

C REACTIVE PROTEIN; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HUMAN; INFLAMMATION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPUTUM SMEAR; SWEAT; SYMPTOMATOLOGY; TUBERCULOSIS; WEIGHT REDUCTION;

EID: 38349064842     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dye C. Lancet. Global epidemiology of tuberculosis. 2006; 367: 938-940.
2. Anderson S R, Maguire H, Carless J. Tuberculosis in London: a decade and a half of no decline in tuberculosis epidemiology and control. Thorax 2007; 62: 162-167.
3. World Health Organization. Global tuberculosis control-surveillance, planning, financing. WHO report 2006. Annex: profiles of high burden countries. WHO/HTM/TB/2006.362. Geneva, Switzerland: WHO, 2006. http://www.who.int/tb/ publications/global_report/2006/annex_1_download/en/index.html Accessed October 2007.
4. Elliott A M, Halwiindi B, Hayes R J, et al. The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. J Trop Med Hyg 1993; 96: 1-11.
5. Mtei L, Matee M, Herfort O, et al. High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis 2005; 40: 1500-1507.
6. Centers for Disease Control and Prevention. Trends in tuberculosis - United States, 1998-2003. MMWR 2004; 53: 209-214.
7. National Institute for Health and Clinical Excellence. CG33 Tuberculosis: Full Guideline - Clinical diagnosis and management of tuberculosis and measures for its prevention and control. London, UK: Royal College of Physicians, 2006. http://www.nice.org.uk/page.aspx?o=297929 Accessed October 2007.
8. Golden M P, Vikram H R. Extra-pulmonary tuberculosis: an overview. Am Fam Physician 2005; 72: 1761-1768.
9. Miller L G, Asch S M, Yu E I, Knowles L, Gelberg L, Davidson P. A population-based survey of tuberculosis symptoms: how atypical are atypical presentations? Clin Infect Dis 2000; 30: 293-299.
10. Barnes P F, Chan L S, Wong S F. The course of fever during treatment of pulmonary tuberculosis. Tubercle 1987; 68: 255-260.
11. Cohen R, Muzaffar S, Capellan J, Azar H, Chinikamwala M. The validity of classic symptoms and chest radiographic configuration in predicting pulmonary tuberculosis. Chest 1996; 109: 420-423.
12. Feingold A O. Tuberculosis without fever. South Med J 1975; 68: 751-753.
13. Hernandez-Garduno E, Cook V, Kunimoto D, Elwood R K, Black W A, FitzGerald J M. Transmission of tuberculosis from smear negative patients: a molecular epidemiology study. Thorax 2004; 59: 286-290.
14. Behr M A, Warren S A, Salamon H, et al. Transmission of Mycobacterium tuberculosis from parients smear-negative for acid-fast bacilli. Lancet 1999; 353: 444-449.
15. Morice A H, McGarvey L, Pavord I, on behalf of the British Thoracic Society Cough Guideline Group. Recommendations for the management of cough in adults. Thorax 2006; 61 (Suppl): S1-S24.
16. Artenstein A W, Kim J H, Williams W J, Chung R C. Isolated peripheral tuberculous lymphadenitis in adults: current clinical and diagnostic issues. Clin Infect Dis 1995; 20: 876-882.
17. Breen R A M, Smith C J, Cropley I, et al. Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy? AIDS 2005; 19: 1201-1206.
18. Pepys M B, Baltz M L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34: 141-212.
19. Choi C M, Kang C I, Jeung W K, Kim D H, Lee C H, Yim J J. Role of the C-reactive protein for the diagnosis of TB among military personnel in South Korea. Int J Tuberc Lung Dis 2007; 11: 233-236.
20. Schleicher G K, Herbert V, Brink A, et al. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Eur Respir J 2005; 25: 688-692.
21. Agranoff D, Fernandez-Reyes D, Papadopoulos M C, et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006; 368: 1012-1021.
22. Pai M, Menzies D. Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis? Clin Infect Dis 2007; 44: 74-77.
23. Liam C K, Lim K H, Srinivas P, Poi P J. Hypercalcaemia in patients with newly diagnosed tuberculosis in Malaysia. Int J Tuberc Lung Dis 1998; 2: 818-823.